Literature DB >> 10777178

Radiation therapy in pancreatic cancer: current practice and future trends.

W R Bodner1, B S Hilaris, D A Mastoras.   

Abstract

Treatment options for pancreatic cancer remain limited due to the large proportion of patients presenting with advanced disease at the time of diagnosis. Surgery offers the best chance for cure. Localized chemoradiation modestly improves median survival in both localized and locally advanced disease. Interstitial brachytherapy and intraoperative radiotherapy improve local control without providing significant impact on overall survival. Technological advances now allow us to deliver three dimensional conformal external beam irradiation with improved efficacy and decreased morbidity. Novel treatment approaches, such as intraoperative photoelectron radiation (Photon Radiosurgery System; PeC Photoelectron Corporation) and the development of more effective radiosensitizers, are presently under investigation.

Entities:  

Mesh:

Year:  2000        PMID: 10777178     DOI: 10.1097/00004836-200004000-00005

Source DB:  PubMed          Journal:  J Clin Gastroenterol        ISSN: 0192-0790            Impact factor:   3.062


  5 in total

Review 1.  The angiogenic switch molecule, secreted FGF-binding protein, an indicator of early stages of pancreatic and colorectal adenocarcinoma.

Authors:  Elena Tassi; Anton Wellstein
Journal:  Semin Oncol       Date:  2006-12       Impact factor: 4.929

2.  Direct in vivo injection of 131I-GMS and its distribution and excretion in rabbit.

Authors:  Yu Ma; Yi Wan; Dong-Hui Luo; Li-Geng Duan; Lin Li; Chuan-Qin Xia; Xiao-Li Chen
Journal:  World J Gastroenterol       Date:  2010-05-07       Impact factor: 5.742

3.  L-Canavanine as a radiosensitization agent for human pancreatic cancer cells.

Authors:  Aimee K Bence; Val R Adams; Peter A Crooks
Journal:  Mol Cell Biochem       Date:  2003-02       Impact factor: 3.396

4.  Tumor angiogenesis: initiation and targeting - therapeutic targeting of an FGF-binding protein, an angiogenic switch molecule, and indicator of early stages of gastrointestinal adenocarcinomas -.

Authors:  Elena Tassi; Anton Wellstein
Journal:  Cancer Res Treat       Date:  2006-12-31       Impact factor: 4.679

5.  Pilot trial of endoscopic ultrasound-guided interstitial chemoradiation of UICC-T4 pancreatic cancer.

Authors:  Siyu Sun; Nan Ge; Sheng Wang; Xiang Liu; Guoxin Wang; Jintao Guo
Journal:  Endosc Ultrasound       Date:  2012-04       Impact factor: 5.628

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.